Two Cases of Acquired Hemophilia A Successfully Treated with Oral Steroid or Danazol
Korean Journal of Hematology
;
: 58-63, 2005.
Artículo
en Coreano
| WPRIM
| ID: wpr-720446
ABSTRACT
Acquired Hemophilia A is a rare and considerably life-threatening coagulopathy, which is caused by the development of autoantibodies against factor VIII (FVIII) in non-hemophilic adults. Acquired FVIII inhibitors can be associated with diverse conditions, such as malignant disorders, medications, autoimmune diseases, postpartum states and others. These autoantibodies inhibit normal coagulation, had results in bleeding complications, which can contribute to mortality in a high percentages of cases. Effective control of the disorder can be achieved by prompt diagnosis and appropriate managements. Generally, the managements of acquired hemophilia A are aimed at treating the acute bleeding and eliminating inhibitors by immunosuppression. Although a range of treatment options exists for patients with acquired hemophilia A, there is no consensus with regard to the optimal therapies for this disorder. Herein, two cases, an 82-year-old man and a 78-year-old man who were successfully treated by steroid or danazol, which is a relatively mild immunosuppressive agent, are reported.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Autoanticuerpos
/
Enfermedades Autoinmunes
/
Factor VIII
/
Mortalidad
/
Terapia de Inmunosupresión
/
Danazol
/
Consenso
/
Periodo Posparto
/
Diagnóstico
/
Hemofilia A
Tipo de estudio:
Estudio diagnóstico
/
Guía de Práctica Clínica
/
Estudio pronóstico
Límite:
Adulto
/
Anciano
/
Aged80
/
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Hematology
Año:
2005
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS